New combo aims to beat hairy cell leukemia with fewer side effects
Disease control
Completed
This study tested a new treatment for hairy cell leukemia using two drugs: vemurafenib (a pill) and rituximab (an IV infusion). The goal was to see if this combination works better and causes fewer side effects than standard chemotherapy. The study included 15 adults with hairy c…
Phase: PHASE2 • Sponsor: Scripps Health • Aim: Disease control
Last updated May 14, 2026 12:02 UTC